Lalit Baregama

Chief Business Officer @Symbiotec Pharmalab Limited

Indore, MP, IN
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Apr 2024 — Present

Chief Business Officer @Symbiotec Pharmalab Limited

View department →

Indore, IN

Global Sales and Business Development

EDUCATION

1994 — 1999

Mohanlal Sukhadia University

BSc, MSc, Organic Chemistry

1999 — 2002

Mohanlal Sukhadia University

PhD, Medicinal Chemistry

SKILLS

HplcPharmacologyRegulatory AffairsLifesciencesPurificationNmrValidationMedicinal ChemistryHeterocyclic ChemistryClinical DevelopmentLong-Term Customer RelationshipsManagementR&DStrategic PartnershipsGlpIntellectual PropertyParallel SynthesisDrug DesignGlobal Business DevelopmentGmpResearchChemistryGeneric ProgrammingProcess DevelopmentAnalytical ChemistryDrug DevelopmentPatentsBiopharmaceuticalsProject ManagementCROInternational Business DevelopmentPharmaceuticsDrug DiscoveryGenericsOrganic SynthesisFormulationTechnology TransferDrug DeliveryOrganic ChemistryLc-Ms

ABOUT LALIT BAREGAMA

Business growth partner for new drug development, API, formulation dossiers, licensing, CMO/CDMO to reach the product globally\"• PhD in Medicinal Chemistry.• Twenty two years of International Business Development and long-term partnership projects accomplishments in Pharmaceutical industry by working with Morepen, Viwit, Cadila, WuxiAppTec, Ranbaxy, HiKAL and Western Drugs.• Significant business value creation for specific country/region through long-term business partnership, B2B, product portfolio development/acquisition, licensing (in & out), M&A, FTE/FFS/FFP, joint venture and co-development.• New Product development and life cycle management: Market evaluation, Product selection, R&D, technology development, piloting, clinical trials and commercialization as per respective country regulatory requirement.• Business Development, new market entry, project accomplishment from inception to commercialization for Discovery-API-Formulation (CRO, CDMO, FTE/FFS) for Europe, APAC and US customers.• Publication: 50 Patents, 14 Research Papers, 20 Conference Presentations, 18 Abstracts in conferences.Recent speaker presentations and panel discussions:• Panelist: Generics and Biosimilars PPM Summit-2021, PPM World tour, Munich.• Invited speaker: PharmaSynergy-2021, International conference and BD & Licensing partnering meetings.• Invited speaker and panelist: Phar-East 2018, International Conference on Pharmaceuticals, Singapore.• Invited speaker: Chemspec Asia-2013, International Conference-AEC 2015, Bangkok, Thailand.• Invited speaker: InformEx USA International Conference-2013, Anaheim-CA, USA.• Invited speaker & Panelist: Contract Manufacturing World Asia- Bio Pharma Asia Convention 2012, Singapore.• Panelist: InformEx International Conference on Life Cycle Management of the Drugs-2012, New Orleans, USA.• CPhI International Conferences “Contract Partnership Executive Summit (C-Level)-2011” on invitation at Frankfurt, Germany.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.